Febbo Phillip G. (CIK 1649245) reported 14 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-04). Recent activity: Sell VCYT (3,639 shares), Sell VCYT (10,405 shares), Sell VCYT (2,705 shares), Sell VCYT (3,730 shares), Buy VCYT (29,603 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-04 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Sell | 3,639 | $163,318 |
| 2026-09-04 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Sell | 10,405 | $446,305 |
| 2026-09-04 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Sell | 2,705 | $118,105 |
| 2026-06-04 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Sell | 3,730 | $178,294 |
| 2026-03-10 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Buy | 29,603 | $0 |
| 2026-03-10 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Buy | 6,578 | $0 |
| 2026-03-04 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Sell | 6,035 | $217,320 |
| 2026-03-04 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Sell | 13,425 | $485,448 |
| 2026-03-02 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Buy | 71,806 | $0 |
| 2026-03-02 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Sell | 24,486 | $948,832 |
| 2025-12-04 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Sell | 2,955 | $136,403 |
| 2025-10-07 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Sell | 8,349 | $300,731 |
| 2025-09-04 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Sell | 2,955 | $88,975 |
| 2025-06-04 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Sell | 2,955 | $79,017 |
来源：SEC Form 4 申报文件 · 截至 2026-09-04